Asporin activates coordinated invasion of scirrhous gastric cancer and cancer-associated fibroblasts

Oncogene

Volumn 34, Issue 5, 2015, Pages 650-660

  Satoyoshi, R ^a   Kuriyama, S ^a   Aiba, N ^a   Yashiro, M ^b   Tanaka, M ^a  

^a AKITA UNIVERSITY   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

aspirin; CAF; rac1; scirrhous gastric cancer; SLRP

Indexed keywords

ASPN PROTEIN, HUMAN; CD44 PROTEIN, HUMAN; HERMES ANTIGEN; RAC1 PROTEIN; RAC1 PROTEIN, HUMAN; SCLEROPROTEIN;

ADENOCARCINOMA; ANIMAL; BIOSYNTHESIS; COCULTURE; DRUG SCREENING; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; PARACRINE SIGNALING; PATHOLOGY; STOMACH TUMOR; TUMOR INVASION; TUMOR MICROENVIRONMENT;

ADENOCARCINOMA, SCIRRHOUS; ANIMALS; ANTIGENS, CD44; COCULTURE TECHNIQUES; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; NEOPLASM INVASIVENESS; PARACRINE COMMUNICATION; RAC1 GTP-BINDING PROTEIN; STOMACH NEOPLASMS; TUMOR MICROENVIRONMENT; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85028229627     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.584     Document Type: Article

References (31)

1. Yashiro M, Hirakawa K. Cancer-stromal interactions in scirrhous gastric carcinoma. Cancer Microenviron 2010; 3: 127-135.
2. Ungefroren H, Sebens S, Seidl D, Lehnert H, Hass R. Interaction of tumor cells with the microenvironment. Cell Commun Signal 2011; 9: 18.
3. Karagiannis GS, Poutahidis T, Erdman SE, Kirsch R, Riddell RH, Diamandis EP. Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue. Mol Cancer Res 2012; 10: 1403-1418.
4. Fuyuhiro Y, Yashiro M, Noda S, Kashiwagi S, Matsuoka J, Doi Y et al. Upregulation of cancer-associated myofibroblasts by TGF-b from scirrhous gastric carcinoma cells. Br J Cancer 2011; 105: 996-1001.
5. Duval E, Bigot N, Hervieu M, Kou I, Leclercq S, Galé ra P et al. Asporin expression is highly regulated in human chondrocytes. I Mol Med 2011; 17: 816-823.
6. Nakajima M, Kizawa H, Saitoh M, Kou I, Miyazono K, Ikegawa S. Mechanisms for asporin function and regulation in articular cartilage. J Biol Chem 2007; 282: 32185-32192.
7. Merline R, Schaefer RM, Schaefer L. The matricellular functions of small leucinerich proteoglycans (SLRPs). J Cell Commun Signal 2009; 3: 323-335.
8. Chen S, Birk DE. The regulatory roles of small leucine-rich proteoglycans in extracellular assembly. FEBS J 2013; 280: 2120-2137.
9. Gruber HE, Ingram JA, Hoelscher GL, Zinchenko N, Hanley EN, Sun Y. Asporin a susceptibility gene in osteoarthritis, is expressed at higher levels in the more degenerate human intervertebral disc. Arthritis Res Ther 2009; 11: R47.
10. Turashvili G, Bouchal J, Baumforth K, Wei W, Dziechciarkova M, Ehrmann J et al. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer 2007; 7: 55.
11. Klee EW, Bondar OP, Goodmanson MK, Dyer RB, Erdogan S, Bergstralh EJ et al. Candidate serum biomarkers for prostate adenocarcinoma identified by mRNA differences in prostate tissue and verified with protein measurements in tissue and blood. Clin Chem 2012; 58: 599-609.
12. Horie M, Saito A, Mikami Y, Ohshima M, Morishita Y, Nakajima J et al. Characterization of human lung cancer-associated fibroblasts in three-dimensional in vitro co-culture model. Biochem Biophys Res Comm 2012; 423: 158-163.
13. Zö ller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev 2011; 11: 254-267.
14. Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, Harrington K et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 2007; 9: 1392-1400.
15. Sugimoto H, Mundel TM, Kieran MW, Kalluri R. Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther 2006; 5: 1640-1646.
16. Quante M, Tu SP, Tomita H, Gonda T, Wang SSW, Takashi S et al. Bone marrowderived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell 2011; 19: 257-272.
17. Franco OE, Shaw AK, Strand DW, Hayward SW. Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol 2010; 21: 33-39.
18. Terawaki S, Kitano K, Mori T, Zhai Y, Higuchi Y, Itoh N et al. The PHCCEx domain of Tiam1/2 is a novel protein-and membrane-binding module. EMBO J 2010; 29: 236-250.
19. Santra M, Eichstetter I, Iozzo RV. An anti-oncogenic role for decorin. Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells. J Biol Chem 2000; 275: 35153-35161.
20. Iozzo RV, Moscatello DK, McQuillan DJ, Eichstetter I. Decorin is a biological ligand for the epidermal growth factor receptor. J Biol Chem 1999; 274: 4489-4492.
21. Csordás G, Santra M, Reed CC, Eichstetter I, McQuillan DJ, Gross D et al. Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J Biol Chem 2000; 275: 32879-32887.
22. Zhu JX, Goldoni S, Bix G, Owens RT, McQuillan DJ, Reed CC et al. Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis. J Biol Chem 2005; 280: 32468-32479.
23. Seidler DG, Goldoni S, Agnew C, Cardi C, Thakur ML, Owens RT et al. Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation. J Biol Chem 2006; 281: 26408-26418.
24. Patel S, Santra M, McQuillan DJ, Iozzo RV, Thomas AP. Decorin activates the epidermal growth factor receptor and elevates cytosolic Ca2\+ in A431 carcinoma cells. J Biol Chem 1998; 27: 121-3124.
25. Santra M, Reed CC, Iozzo RV. Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitope. J Biol Chem 2002; 277: 35671-35681.
26. Iozzo RV, Sanderson RD. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J Cell Mol Med 2011; 15: 1013-1031.
27. Edwards IJ. Proteoglycans in prostate cancer. Nat Rev Urol 2012; 9: 196-206.
28. Chong HC, Tan CK, Huang RL, Tan NS. Matricellular-proteins: a sticky affair with cancers. J Oncol 2012; 2012: 351089.
29. Penã C, Céspedes MV, Lindh MB, Kiflemariam S, Mezheyeuski A, Edqvist PH et al. STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer. Cancer Res 2013; 73: 1287-1297.
30. Shimamura S, Sasaki K, Tanaka M. The Src substrate SKAP2 regulates actin assembly by interacting with WAVE2 and cortactin proteins. J Biol Chem 2013; 288: 1171-1183.
31. Hagiyama M, Ichiyanagi N, Kimura KB, Murakami Y, Ito A. Expression of a soluble isoform of cell adhesion molecule 1 in the brain and its involvement in directional neurite outgrowth. Am J Pathol 2009; 174: 2278-2289.